Neurocrine Biosciences | NBIX - Ação

Preço das Ações
128.89
Mudança Diária
-2.75 -2.09%
Mensal
-0.50%
Anual
41.84%
Q2 Previsão
125.37




Ação Alterar Data
AbbVie USD 4.95B 13M 2025-12
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Cytokinetics USD 0 0 2023-12
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Repligen USD 170.46M 10.14M 2025-12
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12